SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity

被引:163
作者
Barker, TH
Baneyx, G
Cardó-Vila, M
Workman, GA
Weaver, M
Menon, PM
Dedhar, S
Rempel, SA
Arap, W
Pasqualini, R
Vogel, V
Sage, EH
机构
[1] Virginia Mason, Benaroya Res Inst, Hope Heart Program, Seattle, WA 98101 USA
[2] Univ Washington, Dept Bioengn, Seattle, WA 98101 USA
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Henry Ford Hosp, Barbara Jane Levy Lab, Hermelin Brain Tumor Ctr, Detroit, MI 48202 USA
[5] British Columbia Canc Agcy, Jack Bell Res Ctr, Vancouver, BC V5Z 1L3, Canada
[6] ETH, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland
关键词
D O I
10.1074/jbc.M504663200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SPARC, a 32-kDa matricellular glycoprotein, mediates interactions between cells and their extracellular matrix, and targeted deletion of Sparc results in compromised extracellular matrix in mice. Fibronectin matrix provides provisional tissue scaffolding during development and wound healing and is essential for the stabilization of mature extracellular matrix. Herein, we report that SPARC expression does not significantly affect fibronectin-induced cell spreading but enhances fibronectin-induced stress fiber formation and cell-mediated partial unfolding of fibronectin molecules, an essential process in fibronectin matrix assembly. By phage display, we identify integrin-linked kinase as a potential binding partner of SPARC and verify the interaction by co-immunoprecipitation and colocalization in vitro. Cells lacking SPARC exhibit diminished fibronectin-induced integrin-linked kinase activation and integrin-linked kinase-dependent cell-contractile signaling. Furthermore, induced expression of SPARC in SPARC-null fibroblasts restores fibronectin-induced integrin-linked kinase activation, downstream signaling, and fibronectin unfolding. These data further confirm the function of SPARC in extracellular matrix organization and identify a novel mechanism by which SPARC regulates extracellular matrix assembly.
引用
收藏
页码:36483 / 36493
页数:11
相关论文
共 65 条
[41]   MODULATION OF ENDOTHELIAL-CELL SHAPE BY SPARC DOES NOT INVOLVE CHELATION OF EXTRACELLULAR CA-2+ AND MG-2+ [J].
SAGE, EH .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1992, 70 (01) :56-62
[42]  
SAGE EH, 2004, CURRENT PROTOCOLS CE
[43]   SPARC, A SECRETED PROTEIN ASSOCIATED WITH CELLULAR PROLIFERATION, INHIBITS CELL SPREADING INVITRO AND EXHIBITS CA-+2-DEPENDENT BINDING TO THE EXTRACELLULAR-MATRIX [J].
SAGE, H ;
VERNON, RB ;
FUNK, SE ;
EVERITT, EA ;
ANGELLO, J .
JOURNAL OF CELL BIOLOGY, 1989, 109 (01) :341-356
[44]  
SAGE H, 1984, J BIOL CHEM, V259, P3993
[45]   SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion [J].
Schmidt, MHH ;
Chen, BH ;
Randazzo, LM ;
Bögler, O .
JOURNAL OF CELL SCIENCE, 2003, 116 (14) :2845-2855
[46]   Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices [J].
Schönherr, E ;
O'Connell, BC ;
Schittny, J ;
Robenek, H ;
Fastermann, D ;
Fisher, LW ;
Plenz, G ;
Vischer, P ;
Young, MF ;
Kresse, H .
EUROPEAN JOURNAL OF CELL BIOLOGY, 1999, 78 (01) :44-55
[47]   Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly [J].
Schwarzbauer, JE ;
Sechler, JL .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (05) :622-627
[48]   A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly [J].
Sechler, JL ;
Rao, HW ;
Cumiskey, AM ;
Vega-Colón, I ;
Smith, MS ;
Murata, T ;
Schwarzbauer, JE .
JOURNAL OF CELL BIOLOGY, 2001, 154 (05) :1081-1088
[49]   Modulatory roles for integrin activation and the synergy site of fibronectin during matrix assembly [J].
Sechler, JL ;
Corbett, SA ;
Schwarzbauer, JE .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (12) :2563-2573
[50]   Functional roles of Akt signaling in mouse skin tumorigenesis [J].
Segrelles, C ;
Ruiz, S ;
Perez, P ;
Murga, C ;
Santos, M ;
Budunova, IV ;
Martínez, J ;
Larcher, F ;
Slaga, TJ ;
Gutkind, JS ;
Jorcano, JL ;
Paramio, JM .
ONCOGENE, 2002, 21 (01) :53-64